MedPath

Efficacy of transcranial direct current stimulation (tDCS) in modulating neurocognitive markers of obsessive-compulsive disorder

Not Applicable
Conditions
F42.0
F42.1
F42.2
Predominantly obsessional thoughts or ruminations
Predominantly compulsive acts [obsessional rituals]
Mixed obsessional thoughts and acts
Registration Number
DRKS00016807
Lead Sponsor
Humboldt-Universität zu Berlin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criterion for patients: Primary diagnosis of obsessive-compulsive disorder (ICD-10, F42.-) as assessed by the Structured Clinical Interview for DSM-V Axis I Disorders
- German as native language
- Ability to provide written informed consent

Exclusion Criteria

- Current or lifetime diagnosis of a substance-related disorder, schizophrenia spectrum disorder, delusional disorder, bipolar disorder, neurological disorder of the CNS
- Verbal IQ < 85
- Uncorrectable visual, auditory, or motor impairments
- Benzodiazepines within the last week, neuroleptics during the last three months
- Contraindications for transcranial direct current stimulation: any metal or electronic implants in the head or upper body (e.g., cochlear implant, brain stimulator, aneurysm clip or stent, cardiac pacemaker), skin disorder or skin condition at or near stimulation locations (e.g., psoriasis or eczema), pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Performance monitoring: <br>- Behavioral performance (reaction time and accuracy) and event-related potentials (ERN, Pe, CRN) during the flanker task at session 1 and session 2<br><br>Affective evaluation of self-generated actions: <br>- Behavioral performance (reaction time and accuracy) and event-related potentials (ERN, Pe, CRN) during the evaluative go/no-go task (go/no-go task combined with an affective word categorization task) at session 1 and session 2<br>- Skin conductance response and heart rate during the flanker task and the evaluative go/no-go task at session 1 and session 2
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath